Trial Profile
Assessment of Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With a Single Dose of JE-CV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- 27 Dec 2016 Status changed from not yet recruiting to completed, according to the results published in the Pediatric Infectious Disease Journal
- 27 Dec 2016 Results of studies JEC05 and JEC24 published in the Pediatric Infectious Disease Journal
- 15 Oct 2013 New trial record